Aprogenex deal

Under the original June 1993 agreement, Dianon is using the test to conduct clinical investigations under its own protocols in the U.S. Dianon was to pay APG (Houston) $10 plus a royalty for each test sold before FDA approval and $20 each after approval. As amended, the agreement calls for Dianon (Stratford, Conn.) to pay $35 per test prior to approval and $60 after approval. ...